Candida tropicalis biofilm inhibition by ZnO nanoparticles and EDTA

Vinoth Jothiprakasam1, Murugan Sambantham1, Stalin Chinnathambi1

  • 1CAS in Marine Biology, Annamalai University, Parangipettai-608 502, Tamil Nadu, India.

Archives of Oral Biology
|September 23, 2016
PubMed
Abstract

Insights

Zinc Oxide (ZnO) nanoparticles and EDTA effectively inhibit Candida tropicalis biofilms, offering a new strategy for preventing medical device-associated infections. These agents show promise against both fluconazole-susceptible and resistant strains.

Area of Science:

  • Microbiology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Candida tropicalis biofilms pose significant challenges in treating chronic and medical device-associated infections.
  • Biofilm formation by C. tropicalis can lead to immune evasion and resistance to antifungal therapies.

Purpose of the Study:

  • To evaluate the efficacy of Zinc Oxide (ZnO) nanoparticles and EDTA against Candida tropicalis biofilms.
  • To explore ZnO nanoparticles synthesized from egg albumin as a potential anti-biofilm agent.

Main Methods:

  • Culturing of fluconazole-susceptible and resistant C. tropicalis strains.
  • Assessing biofilm formation and antifungal effects using ATP bioluminescence and XTT reduction assays.
  • Synthesis of ZnO nanoparticles using egg albumin.

Main Results:

  • Both synthesized ZnO nanoparticles and EDTA demonstrated significant antifungal properties against C. tropicalis biofilms.
  • Effective concentrations varied for susceptible and resistant strains, showing comparable or superior efficacy to fluconazole.

Conclusions:

  • ZnO nanoparticles represent a promising new agent for preventing C. tropicalis biofilms.
  • These findings highlight the potential of ZnO in combating biofilm formation on medical devices.

Related Concept Videos